Group III metabotropic glutamate receptor activation inhibits Ca 2+ influx and nitric oxide synthase activity in bone marrow stromal cells

Journal of Cellular Physiology

Volumn 204, Issue 2, 2005, Pages 704-713

  Foreman, Megan A ^a   Gu, Yuchun ^b,d   Howl, John D ^c   Jones, Sarah ^c   Publicover, Stephen J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^d UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CYCLIC AMP; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 6; METABOTROPIC RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE (CALCIUM,CALMODULIN); THAPSIGARGIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MARROW CELL; CALCIUM TRANSPORT; CELL MEMBRANE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GROWTH REGULATION; HYPERPOLARIZATION; MALE; MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA CELL; SIGNAL TRANSDUCTION; STROMA CELL; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CYCLIC AMP; GLUTAMIC ACID; INTRACELLULAR MEMBRANES; MALE; MEMBRANE POTENTIALS; NITRIC OXIDE SYNTHASE; OSMOLAR CONCENTRATION; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 18844367736     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20353     Document Type: Article

References (65)

1. Afzal F, Polak J, Buttery L. 2004. Endothelial nitric oxide synthase in the control of osteoblastic mineralizing activity and bone integrity. J Pathol 202(4):503-510.
2. Aguirre J, Buttery L, O'Shaughnessy M, Afzal F, Fernandez de Marticorena I, Hukkanen M, Huang P, MacIntyre I, Polak J. 2001. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol 158(1):247-257.
3. Armour KE, Armour KJ, Gallagher ME, Godecke A, Helfrich MH, Reid DM, Ralston SH. 2001. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 142(2):760-766.
4. Aubin JE, Liu F, Malaval L, Gupta AK. 1995. Osteoblast and chondroblast differentiation. Bone 17(2 Suppl):77S-83S.
5. Beresford JN, Owen ME. 1998. Marrow stromal cell culture. Cambridge: Cambridge University Press. pp 26-28.
6. Bhangu PS, Genever PG, Spencer GJ, Grewal TS, Skerry TM. 2001. Evidence for targeted vesicular glutamate exocytosis in osteoblasts. Bone 29(1):16-23.
7. Bianchi G, Muraglia A, Daga A, Corte G, Cancedda R, Quarto R. 2001. Microenvironment and stem properties of bone marrow-derived mesenchymal cells. Wound Repair Regen 9(6):460-466.
8. Bianco P, Riminucci M, Gronthos S, Robey PG. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19(3):180-192.
9. Bidwell JP, Carter WB, Fryer MJ, Heath H, 3rd. 1991. Parathyroid hormone (PTH)-induced intracellular Ca2+ signalling in naive and PTH-desensitized osteoblast-like cells (ROS 17/2.8): Pharmacological characterization and evidence for synchronous oscillation of intracellular Ca2+. Endocrinology 129(6):2993-3000.
10. Birch MA, Genever P, Laketic-Ljubojevic I, Patton AJ, Peet NM, Skerry T. 1997. Glutamate receptor activation is necessary for bone formation. J Bone Miner Res 12:O10.
11. Bizzarri C, Civitelli R. 1994. Activation of the Ca2+ message system by parathyroid hormone is dependent on the cell cycle. Endocrinology 134(1): 133-140.
12. Brenman JE, Bredt DS. 1997. Synaptic signaling by nitric oxide. Curr Opin Neurobiol 7(3):374-378.
13. Brown J, Reading SJ, Jones S, Fitchett CJ, Howl J, Martin A, Longland CL, Michelangeli F, Dubrova YE, Brown CA. 2000. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: A comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 80(1):37-45.
14. Chambers TJ, Fox S, Jagger CJ, Lean JM, Chow JW. 1999. The role of prostaglandins and nitric oxide in the response of bone to mechanical forces. Osteoarthritis Cartilage 7(4):422-423.
15. Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. 1998. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 22(4):295-299.
16. Chow JW, Fox SW, Lean JM, Chambers TJ. 1998. Role of nitric oxide and prostaglandins in mechanically induced bone formation. J Bone Miner Res 13(6):1039-1044.
17. Fleming I, Busse R. 2003. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284(1):R1-R12.
18. Fox SW, Chow JW. 1998. Nitric oxide synthase expression in bone cells. Bone 23(1):1-6.
19. Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3(4):393-403.
20. Garthwaite J, Boulton CL. 1995. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57:683-706.
21. Genever PG, Skerry TM. 2001. Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: Evidence for intrinsic glutamatergic signaling in bone. FASEB J 15(9):1586-1588.
22. Genever PG, Wilkinson DJ, Patton AJ, Peet NM, Hong Y, Mathur A, Erusalimsky JD, Skerry TM. 1999. Expression of a functional N-methyl-D- aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood 93(9):2876-2883.
23. Ghosh PK, Baskaran N, van den Pol AN. 1997. Developmentally regulated gene expression of all eight metabotropic glutamate receptors in hypothalamic suprachiasmatic and arcuate nuclei-a PCR analysis. Brain Res Dev Brain Res 102(1):1-12.
24. Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ. 1999. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 14(1):47-56.
25. Gu Y, Publicover SJ. 2000. Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts. Cross-talk with N-methyl-D-aspartate receptors. J Biol Chem 275(44):34252-34259.
26. Gu Y, Genever PG, Skerry TM, Publicover SJ. 2002. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors. Calcif Tissue Int 70(3):194-203.
27. Helfrich MH, Evans DE, Grabowski PS, Pollock JS, Ohshima H, Ralston SH. 1997. Expression of nitric oxide synthase isoforms in bone and bone cell cultures. J Bone Miner Res 12(7):1108-1115.
28. Hinoi E, Fujimori S, Nakamura Y, Yoneda Y. 2001. Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. Biochem Biophys Res Commun 281(2):341-346.
29. Hinoi E, Fujimori S, Takarada T, Taniura H, Yoneda Y. 2002. Facilitation of glutamate release by ionotropic glutamate receptors in osteoblasts. Biochem Biophys Res Commun 297(3):452-458.
30. Hinoi E, Fujimori S, Yoneda Y. 2003. Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J 17(11):1532-1534.
31. Hinoi E, Takarada T, Ueshima T, Tsuchihashi Y, Yoneda Y. 2004. Glutamate signaling in peripheral tissues. Eur J Biochem 271(1):1-13.
32. Huggett J, Vaughan-Thomas A, Mason D. 2000. The open reading frame of the Na(+)-dependent glutamate transporter GLAST-1 is expressed in bone and a splice variant of this molecule is expressed in bone and brain. FEBS Lett 485(1):13-18.
33. Joly C, Gomeza J, Brabet I, Curry K, Bockaert J, Pin JP. 1995. Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: Comparison with mGluR1. J Neurosci 15(5 Pt 2):3970-3981.
34. Kane MD, Vanden Heuvel JP, Isom GE, Schwarz RD. 1998. Differential expression of group I metabotropic glutamate receptors (mGluRs) in the rat pheochromocytoma cell line PC12: Role of nerve growth factor and ras. Neurosci Lett 252(1):1-4.
35. Kiss JP, Vizi ES. 2001. Nitric oxide: A novel link between synaptic and nonsynaptic transmission. Trends Neurosci 24(4):211-215.
36. Klein-Nulend J, Semeins CM, Ajubi NE, Nijweide PJ, Burger EH. 1995. Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts-correlation with prostaglandin upregulation. Biochem Biophys Res Commun 217(2):640-648.
37. Knopfel T, Lukic S, Leonard T, Flor PJ, Kuhn R, Gasparini F. 1995. Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypes. Neuropharmacology 34(8):1099-1102.
38. Koyama A, Otsuka E, Inoue A, Hirose S, Hagiwara H. 2000. Nitric oxide accelerates the ascorbic acid-induced osteoblastic differentiation of mouse stromal ST2 cells by stimulating the production of prostaglandin E(2). Eur J Pharmacol 391(3):225-231.
39. Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D, Skerry TM. 1999. Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 25(6):631-637.
40. MacPherson H, Noble BS, Ralston SH. 1999. Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells. Bone 24(3):179-185.
41. Mancini L, Moradi-Bidhendi N, Becherini L, Martineti V, MacIntyre I. 2000. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent. Biochem Biophys Res Commun 274(2):477-481.
42. Maniatopoulos C, Sodek J, Melcher AH. 1988. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254(2):317-330.
43. Mason DJ. 2004. Glutamate signalling and its potential application to tissue engineering of bone. Eur Cell Mater 7:12-25.
44. Mason DJ, Suva LJ, Genever PG, Patton AJ, Steuckle S, Hillam RA, Skerry TM. 1997. Mechanically regulated expression of a neural glutamate transporter in bone: A role for excitatory amino acids as osteotropic agents? Bone 20(3):199-205.
45. Muraglia A, Cancedda R, Quarto R. 2000. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113(Pt 7):1161-1166.
46. Nakajima Y, Iwakabe H, Akazawa C, Nawa H, Shigemoto R, Mizuno N, Nakanishi S. 1993. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J Biol Chem 268(16):11868-11873.
47. Nawy S. 2000. Regulation of the on bipolar cell mGluR6 pathway by Ca2+. J Neurosci 20(12):4471-4479.
48. Nawy S, Jahr CE. 1990. Suppression by glutamate of cGMP-activated conductance in retinal bipolar cells. Nature 346(6281):269-271.
49. Palmer RM, Ferrige AG, Moncada S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327(6122): 524-526.
50. Patton AJ, Genever PG, Birch MA, Suva LJ, Skerry TM. 1998. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 22(6):645-649.
51. Peet NM, Grabowski PS, Laketic-Ljubojevic I, Skerry TM. 1999. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J 13(15):2179-2185.
52. Publicover SJ, Thomas GP, el Haj AJ. 1994. Induction of a low voltage-activated, fast-inactivating Ca2+ channel in cultured bone marrow stromal cells by dexamethasone. Calcif Tissue Int 54(2):125-132.
53. Ralston SH. 1997. The Michael Mason Prize Essay 1997. Nitric oxide and bone: What a gas! Br J Rheumatol 36(8):831-838.
54. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS. 1994. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135(1):330-336.
55. Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA, Fernandez-Luna JL, Gonzalez-Macias J. 1995. Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Miner Res 10(3):439-446.
56. Santi MR, Ikonomovic S, Wroblewski JT, Grayson DR. 1994. Temporal and depolarization-induced changes in the absolute amounts of mRNAs encoding metabotropic glutamate receptors in cerebellar granule neurons in vitro. J Neurochem 63(4):1207-1217.
57. Simmons PJ, Torok-Storb B. 1991. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78(1): 55-62.
58. Skerry TM, Genever PG. 2001. Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci 22(4):174-181.
59. Skerry TM, Taylor AF. 2001. Glutamate signalling in bone. Curr Pharm Des 7(8):737-750.
60. Thastrup O, Dawson AP, Scharff O, Foder B, Cullen PJ, Drobak BK, Bjerrum PJ, Christensen SB, Hanley MR. 1989. Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions 27(1-2):17-23.
61. Turner CH, Owan I, Jacob DS, McClintock R, Peacock M. 1997. Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 21(6):487-490.
62. Valerio A, Paterlini M, Boifava M, Memo M, Spano P. 1997. Metabotropic glutamate receptor mRNA expression in rat spinal cord. Neuroreport 8(12): 2695-2699.
63. van't Hof RJ, Ralston SH. 2001. Nitric oxide and bone. Immunology 103(3):255-261.
64. Wiltink A, van den Brink AM, Herrmann-Erlee MP, van der Meer JM, van der Plas A, Willems PH, Van Duijn B, Nijweide PJ, Ypey DL. 1993. Heterogeneity of intracellular calcium responses to parathyroid hormone and thrombin in primary osteoblast-like cells and UMR106-01 cells: Correlations with culture conditions, intracellular calcium concentration and differentiation state. Cell Calcium 14(8):591-600.
65. Zaman G, Pitsillides AA, Rawlinson SC, Suswillo RF, Mosley JR, Cheng MZ, Platts LA, Hukkanen M, Polak JM, Lanyon LE. 1999. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J Bone Miner Res 14(7):1123-1131.